Correction: miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway

Song Wei; Qing Li; Zheng Li; Linjun Wang; Lei Zhang; Zekuan Xu

doi:10.18632/oncotarget.17876

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway

Song Wei, Qing Li, Zheng Li, Linjun Wang, Lei Zhang and Zekuan Xu _

PDF | How to cite

Oncotarget. 2017; 8:34018-34018. https://doi.org/10.18632/oncotarget.17876

Metrics: PDF 3119 views | ?

Present: The current funding acknowledgement information is incorrect.

Correct: The proper funding information appears below. The authors sincerely apologize for this oversight.

FUNDING

This work was supported by the National Natural Science Foundation Project of International Cooperation (NSFC-NIH, 81361120398); the National Natural Science Foundation of China (81272712, 81572362); the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, JX10231801); the Program for Development of Innovative Research Team in the First A liated Hospital of NJMU; 333 Project of Jiangsu Province (BRA2015474).

Original article: Oncotarget. 2016; 7:75185-96. DOI: 10.18632/oncotarget.12092.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17876

Publication Alerts

Corrections:

Correction: miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway